Several studies [3,8,10,24,25,39,41] among these are indicative of a direct correlation between TMEFF2 mRNA downregulation and its promoter methylation, and some also reported promoter methylation to be related to the stages, response to therapy and survival outcomes of the corresponding cancers [8,27,28,31,39]. Here, TMEFF2 is linked to cancer.